Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0000874716-24-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-20 | 2024-02-15 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | $206.94 | +483 | 30.8K | +2% | +$100.0K |
| D | 2024-02-20 | 2024-02-15 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | — | -483 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | M | A | 483 | $206.94 | 30,834.59 | D | — | — | |
| 2 | Derivative | Incentive Stock Option (right-to-buy) | 2024-02-15 | M | D | 483 | — | 0 | D | $206.94 · — to 2029-02-13 | 483 Common Stock | (F2) Not applicable. (F1) Grant of option to buy shares of Issuer common stock that vested on February 14, 2024. |